SharePrinter-friendly versionSend by emailA TitleA TitleA Title A A A W. David Wallace TabsetOverviewBar & Court Admission Bar & Court Admissions District of Columbia Bar Virginia Bar Ohio Bar US Patent and Trademark Office Education Case Western Reserve University School of Law, JD, (cum laude), 1996 State University of New York at Buffalo, MS, 1992 Cornell University, BS, (Chemistry), 1990 W. DavidWallacePartnerWashington, DC T 202.857.6140 E david.wallace@arentfox.com Download vCard David Wallace is a partner in the firm’s Intellectual Property Group. He practices in all areas of intellectual property, with a focus on patent prosecution, counseling and litigation in pharmaceuticals, nutraceuticals, cosmetics, foods, organic, and inorganic chemistry, polymers, medical devices, and biotechnology. David has extensive experience in counseling and defending generic pharmaceutical companies with respect to Hatch-Waxman litigation. Client Work David advises clients in the life sciences on obtaining, enforcing, and designing around patents. This includes preparing and prosecuting patent applications, providing opinions relating to the infringement or validity of patents, licensing, and due diligence investigations of third-party intellectual property portfolios. David has specialized experience in advising generic pharmaceutical companies regarding strategies for filing Abbreviated New Drug Application, including the development of non-infringement and invalidity positions against patents listed by brand companies in the Food and Drug Administration’s Orange Book. Previous Work Prior to joining Arent Fox, David was a partner at a national intellectual property law firm. Professional Activities David is an active member of the American Bar Association and the American Intellectual Property Law Association. Publications, Presentations and Recognitions David is a frequent lecturer and author on topics such as prosecution tips and strategies, case law developments in the US Court of Appeals for the Federal Circuit, prosecution history estoppel, and interviewing strategies. He has also been a judge in the Sutherland Moot Court competition and a faculty member of the Practicing Law Institute. His publications include: “The Impact of the America Invents Act on Patent Applications Filed On or After March 16, 2013,” co-author, with Patricia Granados, January 17, 2013 US Chapter, International Pharmaceutical Law and Practice, co-editor, with Matthew Bender, rev. 2005-08 “Life After Festo: Guarding Against Copyists,” Intellectual Property Today, January 2001 David’s speaking engagements include: “Enforcing Efficiently – Where to Litigate in the US and Europe,” American Intellectual Property Law Association Mid-Winter Meeting, moderator, January 30, 2010 “Recent FDA Decisions Regarding Forfeiture of 180-Day Exclusivity,” Generic Pharmaceutical Association (GPhA) Annual Meeting, February 23, 2009 “Prophesies, Predictions and Patents: How Much Data Is Required to Obtain a Patent in the United States,” Association of University Technology Managers Annual Meeting, February 14, 2009 “Strategies For Efficient Prosecution,” 2008 “Recent Federal Circuit Decisions,” 2006 “Patent Prosecution Tips,” 2005 “Strategies For Responding to Office Actions,” 2003-2004 Life Beyond the Law David enjoys golf, tennis, basketball, reading, and spending time with his family. Newsroom Date Type Title 1 / 17 / 2013 Alert The Impact of the America Invents Act on Patent Applications Filed On or After March 16, 2013 2 / 22 / 2012 Press Release David Wallace Joins Arent Fox’s Intellectual Property Practice
